Clinical Trial Update: Coorticosteroid Regimen in Patients With Anti-PD-1/PD-L1 Induced Pneumonitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a corticosteroid regimen for pneumonitis induced by anti-PD-1/PD-L1 therapy has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Lung Neoplasm

Snippet

Sponsor: National Institute for Tuberculosis and Lung Diseases, Poland | Conditions: Lung Neoplasm Malignant, Interstitial Lung Disease | Phase 4 | Status: SUSPENDED